I alle fem undersøgelser var bedømmelsen, at en betydelig større andel af Xolair- behandlede patienter havde opnået enten en markant forbedring i eller fuldstændig kontrol af deres astma sammenlignet med placebo- patienter.
In all five studies a significantly greater proportion of Xolair treated patients were judged to have achieved either a marked improvement or complete control of their asthma compared to placebo patients.